Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is a double-blind, randomised, placebo-controlled, two-part adaptive clinical trial. The trial is designed to investigate the efficacy and safety of multiple dosing regimens of selepressin and to confirm the efficacy and safety of one dosing regimen in treatment of adult patients with septic shock requiring vasopressor.
Epistemonikos ID: a4d57e6cbd86d2c9272ebe0b2a87a3c27a55f816
First added on: May 12, 2024